{"nct_id":"NCT04008030","title":"A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2019-08-05","start_date_type":"ACTUAL","primary_completion_date":"2024-08-28","primary_completion_date_type":"ACTUAL","completion_date":"2026-06-10","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["BMY"]}